Management of Rhabdomyosarcoma in Pediatric Patients.
This clinical management article outlines multidisciplinary treatment of pediatric rhabdomyosarcoma, emphasizing site-specific surgery, local control, and the need to reduce relapse and long-term treatment morbidity.
Open original publication →What the AI sees
This clinical management article outlines multidisciplinary treatment of pediatric rhabdomyosarcoma, emphasizing site-specific surgery, local control, and the need to reduce relapse and long-term treatment morbidity.
Research significance
The record supports the established clinical rationale for combining chemotherapy, surgery, and radiotherapy; it only implies, without presenting comparative or experimental evidence, that improved local-control and systemic approaches could reduce relapse, late sequelae, and functional impairment.
Source abstract
Treatment of rhabdomyosarcoma (RMS) involves a multimodality approach, including chemotherapy, surgery, and radiotherapy, while minimizing the long-term treatment-related morbidities. This article outlines the key points related to the diagnosis and management of RMS with a focus on current surgical management of RMS at specific tumor sites. There is a need for improved local control approaches and systemic therapy in RMS to reduce locoregional and metastatic relapse, reduce late sequelae of treatment, and improve functional outcomes. Better understanding of the biology of the RMS subtypes found in adult patients, with increased enrollment into cooperative group studies, is required.